Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$109.23 USD
-3.65 (-3.23%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $109.28 +0.05 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ZBH 109.23 -3.65(-3.23%)
Will ZBH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZBH
Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes
Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now
Other News for ZBH
Zimmer Biomet down for third session in a row despite THINK Surgical agreement
Zimmer distribution agreement with THINK 'makes sense,' says Baird
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINIĀ® Miniature Handheld Robotic System for Total Knee Arthroplasty
Zimmer Biomet signs agreement with THINK Surgical for robotic solution
Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference